The U.S. compounding pharmacy industry has quietly become one of the most important segments of healthcare. While traditional pharmaceutical companies manufacture drugs at scale, compounding pharmacies create customized medications tailored to individual patient needs.
Demand has accelerated in recent years due to drug shortages, personalized treatments, hormone therapies, pain management solutions, and the unprecedented growth of GLP-1 weight-loss medications. As healthcare providers search for reliable medication supply and customized therapies, large compounding pharmacies have evolved into sophisticated manufacturing operations serving hospitals, clinics, physicians, and millions of patients nationwide.
Today, FDA-registered outsourcing facilities operate under strict quality requirements, with many investing tens of millions of dollars in sterile manufacturing capabilities. Their role has become increasingly strategic for healthcare systems facing supply chain disruptions and growing patient demand.
The Industry by the Numbers
The U.S. compounding market has expanded significantly over the past decade.
| Metric | Latest Estimate |
|---|---|
| FDA-Registered 503B Outsourcing Facilities | 80+ |
| U.S. Compounding Pharmacies | 7,000+ |
| Annual Compounded Prescriptions | 70+ Million |
| Hospital Use of Compounded Drugs | More than 75% of hospitals |
| Major Regulatory Framework | FDA Sections 503A & 503B |
| Industry Growth Drivers | Drug shortages, personalized medicine, GLP-1 demand |
The industry’s importance increased after recurring shortages of critical medications, including injectable drugs, anesthetics, and weight-management treatments.
Empower Pharmacy: The Industry Giant
Among all U.S. compounding pharmacies, Empower Pharmacy stands out as the largest and most recognized player.
Founded in Houston, Texas, Empower operates both 503A and 503B facilities and is licensed across all 50 states. The company has invested heavily in sterile manufacturing infrastructure and advanced pharmaceutical production technologies.
Its growth has been remarkable.
Reported revenue increased from approximately $119 million in 2022 to roughly $377 million in 2024, representing one of the fastest growth trajectories in the healthcare services sector.
Millions of prescriptions have been dispensed through Empower’s nationwide network. The company’s expansion was fueled by rising demand for hormone therapies, wellness treatments, and compounded GLP-1 medications.
For healthcare executives, Empower demonstrates how compounding pharmacies can evolve from regional businesses into nationally significant healthcare suppliers.
Fagron Sterile Services: A Global Leader with U.S. Strength
Another major force is Fagron Sterile Services, part of the global pharmaceutical company Fagron.
The company specializes in sterile compounded medications supplied to hospitals, surgery centers, and healthcare providers.
Its competitive advantage lies in advanced manufacturing standards, regulatory compliance, and broad distribution capabilities.
Healthcare systems often choose Fagron because of its ability to produce high-quality sterile preparations while maintaining large-scale operational capacity.
Olympia Pharmaceuticals: Growing Through Specialized Therapies
Olympia Pharmaceuticals has emerged as a significant outsourcing facility focused on sterile injectable products.
The company serves physicians, wellness clinics, and healthcare organizations across the United States.
Its portfolio includes hormone therapies, regenerative medicine products, and specialty compounded medications.
Olympia’s continued investment in manufacturing capabilities reflects the growing demand for personalized therapies that traditional pharmaceutical manufacturers may not provide.
Stokes Healthcare and Epicur Pharma
Epicur Pharma, a division of Stokes Healthcare, is another respected name among FDA-registered outsourcing facilities.
The company has built its reputation through sterile drug production and hospital partnerships.
Healthcare organizations value Epicur for its regulatory focus and ability to support critical medication supply during shortage periods.
As hospitals continue seeking dependable suppliers, companies like Epicur play an increasingly important role in maintaining treatment continuity.
The Regulatory Shift Creating New Opportunities
The compounding industry changed dramatically after stronger federal oversight was introduced.
Today, FDA-registered 503B outsourcing facilities must follow Current Good Manufacturing Practices (CGMP), undergo inspections, report adverse events, and maintain detailed production records.
This has created a higher barrier to entry.
Smaller pharmacies often struggle to meet these requirements, while larger organizations continue investing in manufacturing facilities, automation systems, quality laboratories, and compliance teams.
As a result, market share is gradually concentrating among well-capitalized operators.
What Decision Makers Should Watch Next
The future of the industry will be shaped by three major factors:
Drug shortages, which continue creating demand for compounded alternatives.
Personalized medicine, where customized dosages and formulations improve patient outcomes.
Regulatory oversight, which is becoming increasingly stringent as the FDA focuses on product quality and patient safety.
For investors, healthcare executives, and pharmaceutical leaders, the compounding pharmacy sector is no longer a niche market. It has become a critical component of the U.S. healthcare ecosystem, supporting millions of patients while helping providers navigate supply shortages and individualized treatment needs.
The organizations that successfully balance scale, quality, compliance, and innovation will be positioned to lead the next phase of growth in personalized medicine.
Get Easy Access
Access our exclusive, data-rich dashboard dedicated to the pharma industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting provides strategic intelligence and research expertise across the pharmaceutical market, including branded drugs, generic medicines, biologics, biosimilars, specialty pharmaceuticals, OTC products, and drug delivery systems. We support pharmaceutical companies with market analysis, pipeline assessment, and competitive insights to help drive innovation, strengthen commercialization strategies, and capture emerging growth opportunities in the evolving healthcare landscape.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium